c-Abl Inhibitors as Disease-Modifying Therapies for Parkinson's Disease: Gaps and Opportunities. Merchant K, Sullivan J. Mov Disord 2022;37:3-5.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Merchant K, Sullivan J. c-Abl Inhibitors as Disease-Modifying Therapies for Parkinson's Disease: Gaps and Opportunities. Mov Disord 2022;37:3-5.
PMID: 35043450